Skip to main content
    B

    Biomea Fusion Inc (BMEA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.84
    +0.00 (+0.29%)

    Market Cap: $91.10M

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(11/22)
    Avg Surprise
    -13.46%
    Streak
    5 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.22
    Range$-0.28 - $-0.17
    4 analysts
    EPS Revisions
    2
    0
    7d
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.27+18.6%
    60d ago$-0.27+18.6%
    30d ago$-0.220.0%
    7d ago$-0.220.0%
    Current$-0.22
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.20
    Range$-0.40 - $0.00
    4 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    8 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.20---
    Sep 26EST
    		-$-0.22---
    Jun 26
    Reported Aug 6
    		$-0.12$-0.21+42.86%Beat+76.5%
    Mar 26
    Reported May 11
    		$-0.17$-0.19+10.53%Beat+78.8%
    Dec 25
    Reported Mar 24
    		$-0.12$-0.22+45.61%Beat+85.3%
    Sep 25
    Reported Nov 4
    		$-0.24$-0.29+17.24%Beat+73.6%
    Jun 25
    Reported Aug 5
    		$-0.51$-0.51+0.00%Beat+50.5%
    Mar 25
    Reported May 5
    		$-0.80$-0.60-33.33%Miss+26.6%
    Dec 24
    Reported Mar 31
    		$-0.81$-0.91+11.18%Beat+17.3%
    Sep 24
    Reported Oct 29
    		$-0.91$-0.91+0.00%Beat-13.7%
    Jun 24
    Reported Jul 31
    		$-1.03$-1.09+5.50%Beat-47.1%
    Mar 24
    Reported Apr 1
    		$-1.09$-0.93-17.20%Miss-11.2%
    Dec 23
    Reported Jan 9
    		$-0.98$-0.85-15.29%Miss-14.0%
    Sep 23
    Reported Oct 30
    		$-0.80$-0.83+3.61%Beat-2.6%
    Jun 23
    Reported Jul 31
    		$-0.70$-0.88+20.45%Beat-18.6%
    Mar 23
    Reported May 2
    		$-0.98$-0.81-20.99%Miss-75.0%
    Dec 22
    Reported Mar 28
    		$-0.86$-0.81-6.17%Miss-68.6%
    Sep 22
    Reported Nov 7
    		$-0.78$-0.64-21.88%Miss-81.4%
    Jun 22
    Reported Aug 1
    		$-0.59$-0.61+3.28%Beat-78.8%
    Mar 22
    Reported May 16
    		$-0.56$-0.53-5.66%Miss-14.3%
    Dec 21
    Reported Feb 28
    		$-0.51$-0.45-13.33%Miss-
    Sep 21
    Reported Nov 3
    		$-0.43$-0.40-7.50%Miss-
    Jun 21
    Reported Aug 11
    		$-0.33$-0.20-65.00%Miss-
    Mar 21
    Reported Apr 19
    		$-0.49$-0.14-250.00%Miss-

    Key Metrics

    Valuation
    P/E Ratio-1.29EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-164.10%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio3.47xQuick Ratio3.47x
    Trading Statistics
    Beta-0.30Avg Volume2.90M
    52-Week High$2.2452-Week Low$0.80

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.22
    SMA 20$1.34
    SMA 50$1.50
    SMA 200$1.41
    EMA 10$1.18
    EMA 20$1.31
    EMA 50$1.42
    EMA 200$1.45

    MACD

    Line: -0.14Signal: -0.09Hist: -0.05

    ADX

    ADX: 30.6+DI: 12.3-DI: 40.7

    Aroon & PSAR

    Aroon Up24.0
    Aroon Down96.0
    PSAR$1.43

    Bollinger Bands

    Upper Band$1.82
    Lower Band$0.87
    %B Position7121%(Upper)
    Band Width-0.03

    RSI (14-Day)

    Oversold
    25.9

    Momentum Oscillators

    Stoch %K8.2
    Stoch %D16.6
    Williams %R-94.6
    ROC (10d)-35.7%
    Momentum-0.46
    CCI (20d)-217.8
    MFI (14d)14.9

    Volatility Measures

    ATR (14d)$0.14(16.7%)
    StdDev (20d)0.24
    Hist Vol143.7%(High)

    Volume Flow

    VWAP$0.84
    OBV30.2M
    AD Line-12.1M
    CMF (20d)-0.465

    Volume Metrics

    Avg Vol (20d)3.0M
    Vol Ratio1.0x
    VWMA (20d)$1.26

    Pivot Points

    R3$1.15
    R2$1.08
    R1$0.95
    Pivot Point$0.88
    S1$0.76
    S2$0.68
    S3$0.56

    Advanced Oscillators

    TSI-28.41
    Ultimate Osc28.4
    KST-242.15

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$1.22M$0$0$0$6.14M$0
    Cost of Revenue$0$0$47,000$0$0$0N/A$0$0$0$1.13M$0
    Gross Profit$0$0$-47,000$0$0$0$1.22M$0$0$0$5.01M$0
    Operating Expenses$12.77M$12.77M$11.72M$20.80M$21.28M$29.71M$30.07M$34.04M$38.90M$41.06M$37.33M$31.12M
    R&D$9.14M$9.12M$8.12M$14.40M$16.57M$22.90M$25.24M$27.24M$31.82M$33.78M$30.87M$25.35M
    SG&A$3.62M$3.65M$3.60M$4.20M$4.71M$6.82M$4.83M$6.79M$7.07M$7.28M$6.46M$5.77M
    Operating Income$-12,766,000$-12,774,000$-11,719,000$-20,805,000$-21,276,000$-29,712,000$-30,074,000$-34,039,000$-38,898,000$-41,059,000$-37,328,000$-31,119,000
    Interest Income$319,000$430,000$-3,526,000$4.40M$309,000$450,000$772,000$1.25M$1.62M$2.00M$2.44M$2.69M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-12,447,000$-12,344,000$4.61M$-16,407,000$-20,967,000$-29,262,000$-29,302,000$-32,787,000$-37,276,000$-39,061,000$-34,884,000$-28,429,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-12,447,000$-12,344,000$4.61M$-16,407,000$-20,967,000$-29,262,000$-29,302,000$-32,787,000$-37,276,000$-39,061,000$-34,884,000$-28,429,000
    EBITDA$-12,700,000$-12,774,000$-11,672,000$-20,378,000$-20,018,000$-28,478,000$-29,605,000$-33,603,000$-39,474,000$-39,640,000$-36,908,000$-30,700,000
    EBIT$-12,766,000$-12,774,000$-11,719,000$-20,805,000$-21,276,000$-29,712,000$-30,074,000$-34,039,000$-38,898,000$-41,059,000$-37,328,000$-31,119,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about BMEA

    News

    Against 0.1% placebo weight loss, Biomea Fusion (BMEA) reports early oral drug results.

    Biomea Fusion announced positive Phase 1 GLP-131 clinical trial results for its investigational oral GLP-1 receptor agonist...

    Stock Titan•10/14/26•Bullish

    What’s Going On With Biomea Fusion (BMEA) Stock After Hours?

    Biomea Fusion (BMEA) shares fell significantly after announcing Phase 1 results for BMF-650, an investigational oral GLP-1 receptor agonist for weight management. While the study showed weight reduction...

    TradingView•10/14/26•Bearish

    Citizens reiterates Biomea Fusion stock rating on Phase 1 data

    Citizens has reiterated a Market Outperform rating and a $7.00 price target for Biomea Fusion Inc. (NASDAQ: BMEA) following positive Phase 1 clinical trial results for BMF-650. The data validates BMF-650 as an active...

    Investing.com•10/14/26•Bullish

    What’s Going On With Biomea Fusion (BMEA) Stock After Hours?

    Biomea Fusion (NASDAQ: BMEA) shares dropped 28.58% in after-hours trading following the announcement of Phase 1 results for BMF-650...

    Benzinga•10/14/26•Bearish

    Biomea Fusion Announces Phase 1 Results for BMF-650, its Investigational Next-Generation Oral Small Molecule GLP-1 Receptor Agonist

    Biomea Fusion announced positive Phase 1 clinical trial results for BMF-650, an investigational oral small-molecule GLP-1 receptor agonist...

    Yahoo Finance•10/14/26•Bullish

    BMEA Valuation and Fair Value

    P/E
    -1.3x
    P/B
    5.0x
    See GNG's fair value

    BMEA Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -164.1%

    BMEA Competitors

    CompanyTicker
    OnKure Therapeutics, Inc.OKUR
    Immunic IncIMUX
    Insight Molecular Diagnostics Inc.IMDX
    Hyperfine IncHYPR
    Anixa Biosciences IncANIX
    Rallybio CorpRLYB
    Pmv Pharmaceuticals IncPMVP
    Forian IncFORA

    Sector: Healthcare

    BMEA Analyst Ratings

    Consensus
    Buy
    Analysts
    7
    Strong Buy
    2
    Buy
    4
    Hold
    0
    Sell
    0
    Strong Sell
    1

    BMEA Bull Case vs Bear Case

    Bull case

    • 85.7% of BMEA's analyst ratings are Buy or Strong Buy.

    BMEA Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    11.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.22
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 0 down

    Frequently Asked Questions About BMEA

    Does BMEA pay dividends?

    Biomea Fusion Inc (BMEA) does not currently pay a regular dividend.

    What is BMEA's market cap?

    Biomea Fusion Inc (BMEA) has a market capitalization of $91.10M with a current stock price of $0.84.

    Related stocks

    Sector: Healthcare

    All stocks starting with B

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In